289 related articles for article (PubMed ID: 33506301)
41. Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies.
Dinoto A; Bosco A; Sartori A; Bratina A; Bellavita G; Pasquin F; Cheli M; Manganotti P
J Neuroimmunol; 2021 Mar; 352():577488. PubMed ID: 33498007
[TBL] [Abstract][Full Text] [Related]
42. Longitudinally extensive transverse myelitis with positive aquaporin-4 IgG associated with dengue infection: a case report and systematic review of cases.
Comtois J; Camara-Lemarroy CR; Mah JK; Kuhn S; Curtis C; Braun MH; Tellier R; Burton JM
Mult Scler Relat Disord; 2021 Oct; 55():103206. PubMed ID: 34418736
[TBL] [Abstract][Full Text] [Related]
43. [Contribution of spinal cord biopsy to the differential diagnosis of longitudinal extensive transverse myelitis].
Ringelstein M; Aktas O; Harmel J; Prayer D; Jarius S; Wildemann B; Hartung HP; Salhofer-Polanyi S; Leutmezer F; Rommer PS
Nervenarzt; 2014 Oct; 85(10):1298-303. PubMed ID: 25148869
[TBL] [Abstract][Full Text] [Related]
44. A comprehensive review of the advances in neuromyelitis optica spectrum disorder.
Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
Autoimmun Rev; 2023 Dec; 22(12):103465. PubMed ID: 37852514
[TBL] [Abstract][Full Text] [Related]
45. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
46. Investigating paraneoplastic aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder through a data-driven approach.
Dinoto A; Borin GU; Campana G; Carta S; Ferrari S; Mariotto S
Eur J Neurol; 2022 Nov; 29(11):3466-3472. PubMed ID: 35767391
[TBL] [Abstract][Full Text] [Related]
47. Paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian dysgerminoma: a case report and literature review.
Liu P; Wang S; Zhang C; Li Y
Front Immunol; 2024; 15():1424243. PubMed ID: 38947316
[TBL] [Abstract][Full Text] [Related]
48. Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Iorio R; Rindi G; Erra C; Damato V; Ferilli M; Sabatelli M
Mult Scler; 2015 May; 21(6):791-4. PubMed ID: 25716881
[TBL] [Abstract][Full Text] [Related]
49. Neuromyelitis Optica and Skin.
Misery L; Genestet S; Zagnoli F
Dermatology; 2022; 238(5):823-828. PubMed ID: 35249011
[TBL] [Abstract][Full Text] [Related]
50. Neuromyelitis optica: atipic clinic presentation.
Koç ER; Ersoy A; Ilhan A
Neurol Sci; 2012 Dec; 33(6):1439-42. PubMed ID: 22210129
[TBL] [Abstract][Full Text] [Related]
51. [A case report of neuromyelitis optica spectrum disorder with lesions of the medulla oblongata].
Sokhor NR; Yasniy OR
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):121-125. PubMed ID: 35394731
[TBL] [Abstract][Full Text] [Related]
52. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.
Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL
Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482
[TBL] [Abstract][Full Text] [Related]
53. Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy.
Munger KC; Samkoff LM
Mult Scler Relat Disord; 2020 Jan; 37():101442. PubMed ID: 32173005
[TBL] [Abstract][Full Text] [Related]
54. Acute anosmia in neuromyelitis optica spectrum disorder.
Marshall J; Kleerekooper I; Davagnanam I; Trip SA
Mult Scler; 2020 Dec; 26(14):1958-1960. PubMed ID: 32228206
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
56. Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature.
Nardone R; Fitzgerald RT; Bailey A; Zuccoli G
Clin Neurol Neurosurg; 2015 Feb; 129():57-61. PubMed ID: 25544684
[TBL] [Abstract][Full Text] [Related]
57. Late-onset neuromyelitis optica spectrum disorder: A case series from Iran.
Ghadiri F; Eskandarieh S; Sahraian MA; Azimi A; Moghadasi AN
Rev Neurol (Paris); 2022 Mar; 178(3):249-252. PubMed ID: 34776261
[TBL] [Abstract][Full Text] [Related]
58. [Differential diagnosis of neuromyelitis optica spectrum disorders].
Tanaka K; Tanaka M
Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
[TBL] [Abstract][Full Text] [Related]
59. Bright spotty lesions as an imaging marker for neuromyelitis optica spectrum disorder.
Salama S; Levy M
Mult Scler; 2022 Oct; 28(11):1663-1666. PubMed ID: 33635151
[TBL] [Abstract][Full Text] [Related]
60. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
Berger B; Hottenrott T; Rauer S; Stich O
BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
